OMEGA THERAPEUTICS IN

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results

14 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

15 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications

17 Sep 2024 07:00:02 By Nasdaq GlobeNewswire

Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research

14 Aug 2024 07:00:08 By Nasdaq GlobeNewswire

Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

06 Aug 2024 07:00:09 By Nasdaq GlobeNewswire

Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

24 Jun 2024 07:00:53 By Nasdaq GlobeNewswire

Omega Therapeutics To Participate In Two Upcoming Investor Conferences

30 May 2024 07:00:59 By Nasdaq GlobeNewswire

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

29 May 2024 07:00:17 By Nasdaq GlobeNewswire

Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers

08 May 2024 07:00:00 By Nasdaq GlobeNewswire

Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

06 May 2024 07:00:02 By Nasdaq GlobeNewswire

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting

23 Apr 2024 07:00:02 By Nasdaq GlobeNewswire

Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control

09 Apr 2024 07:00:31 By Nasdaq GlobeNewswire

Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

28 Mar 2024 09:15:05 By Nasdaq GlobeNewswire

Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024

06 Mar 2024 07:00:08 By Nasdaq GlobeNewswire

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

02 Jan 2024 16:05:13 By Nasdaq GlobeNewswire

Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

04 Dec 2023 16:00:22 By Nasdaq GlobeNewswire

Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference

20 Nov 2023 16:00:00 By Nasdaq GlobeNewswire

Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis

13 Nov 2023 07:00:32 By Nasdaq GlobeNewswire

Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

09 Nov 2023 07:00:17 By Nasdaq GlobeNewswire

Omega Therapeutics to Participate in The Jefferies London Healthcare Conference

07 Nov 2023 16:00:20 By Nasdaq GlobeNewswire